The Clorox Company (NYSE:CLX) Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC lessened its stake in The Clorox Company (NYSE:CLX - Free Report) by 4.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 60,435 shares of the company's stock after selling 3,030 shares during the quarter. Yousif Capital Management LLC's holdings in Clorox were worth $9,815,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. State Street Corp boosted its holdings in Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock valued at $1,332,947,000 after acquiring an additional 245,525 shares during the last quarter. Mizuho Securities USA LLC raised its holdings in shares of Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the period. Geode Capital Management LLC lifted its stake in shares of Clorox by 1.1% in the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company's stock valued at $491,713,000 after purchasing an additional 33,970 shares in the last quarter. Stifel Financial Corp grew its holdings in shares of Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company's stock worth $380,370,000 after purchasing an additional 37,967 shares during the period. Finally, Van ECK Associates Corp increased its position in Clorox by 2.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company's stock worth $237,372,000 after purchasing an additional 31,510 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Up 0.6 %

Shares of CLX stock traded up $0.91 during mid-day trading on Friday, reaching $148.51. 1,074,015 shares of the company were exchanged, compared to its average volume of 1,380,263. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94. The business's 50 day simple moving average is $161.06 and its 200 day simple moving average is $158.88. The company has a market capitalization of $18.38 billion, a P/E ratio of 40.58, a P/E/G ratio of 2.52 and a beta of 0.42. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the company posted $2.16 earnings per share. Research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.29%. The ex-dividend date is Wednesday, January 29th. Clorox's payout ratio is currently 133.33%.

Analyst Ratings Changes

CLX has been the topic of a number of recent research reports. Evercore ISI lifted their price target on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Wells Fargo & Company boosted their price objective on Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 4th. Finally, StockNews.com lowered Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $158.21.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.